Profile data is unavailable for this security.
About the company
Novozymes A/S is a Denmark-based biotechnology company engaged in the production and sale of industrial enzymes, microorganisms and biopharmaceutical ingredients. The Company operates in four geographical regions: Europe, Middle East & Africa (including Denmark), North America, Asia Pacific and Latin America. It develops and distributes solutions within the market areas agriculture, bioenergy, food & beverages, household care, leather, pharmaceuticals, forest products, textile and wastewater solutions. Novozymes operates through a range of partnerships with companies, such as Adisseo, Beta Renewables, DONG Energy and Monsanto, and is a parent company of Novozymes Belgium BVBA, Novozymes BioAg Limited, Novozymes Canada Limited, Albumedix A/S and Organobalance GmbH, among others.
- Revenue in DKK (TTM)17.81bn
- Net income in DKK3.63bn
- Incorporated2000
- Employees6.79k
- LocationNovozymes A/SKrogshoejvej 36BAGSVAERD 2880DenmarkDNK
- Phone+45 44460000
- Fax+45 44469999
- Websitehttps://www.novozymes.com/
More ▼
Mergers & acquisitions
| Acquired company | NZYM B:CPH since announced | Transaction value |
|---|---|---|
| Chr Hansen Holding A/S | -21.07% | 1.81bn |
| Chr Hansen Holding A/S | -21.07% | 9.62bn |
Data delayed at least 15 minutes, as of May 31 2023 12:35 BST.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Azelis Group NV | 30.60bn | 1.59bn | 41.78bn | 3.83k | 25.23 | 2.26 | 18.48 | 1.37 | 0.9117 | 0.9117 | 17.57 | 10.20 | 0.9174 | 5.78 | 8.37 | 1,074,275.00 | 4.89 | -- | 6.06 | -- | 23.00 | -- | 5.33 | -- | 0.8374 | 7.52 | 0.3705 | -- | 45.34 | -- | 214.65 | -- | -- | -- |
| Turkiye Sise ve Cam Fabrikalari AS | 36.17bn | 6.14bn | 43.74bn | 24.90k | 6.94 | 1.66 | 5.23 | 1.21 | 6.07 | 6.07 | 36.23 | 25.46 | 0.801 | 4.33 | 6.51 | 4,281,411.00 | 14.26 | 12.90 | 21.88 | 18.93 | 34.13 | 34.32 | 17.80 | 20.92 | 1.29 | -- | 0.3364 | 13.02 | 197.43 | 53.15 | 113.99 | 73.64 | 54.04 | 38.75 |
| Arkema SA | 83.32bn | 5.60bn | 46.79bn | 21.10k | 8.57 | 0.8548 | 4.33 | 0.5616 | 9.77 | 9.77 | 147.09 | 97.95 | 0.8207 | 5.91 | 6.59 | 548,059.90 | 5.64 | 6.96 | 6.95 | 8.40 | 20.83 | 21.82 | 6.87 | 8.33 | 1.59 | 14.59 | 0.3288 | 27.31 | 21.34 | 6.77 | -26.60 | 11.94 | 9.72 | 8.13 |
| Umicore SA | 189.44bn | 4.24bn | 49.18bn | 11.57k | 11.32 | 1.83 | 7.33 | 0.2596 | 2.37 | 2.37 | 105.68 | 14.64 | 2.68 | 7.59 | 13.89 | 2,199,354.00 | 6.03 | 5.17 | 10.16 | 8.58 | 6.50 | 6.28 | 2.25 | 1.94 | 0.763 | 7.85 | 0.3966 | 30.44 | 5.74 | 16.31 | -7.93 | 21.54 | 5.46 | 2.71 |
| Imcd NV | 34.27bn | 2.33bn | 60.40bn | 4.32k | 25.88 | 4.84 | 19.40 | 1.76 | 5.50 | 5.50 | 80.83 | 29.39 | 1.33 | 6.25 | 6.96 | 1,064,421.00 | 9.05 | 6.65 | 12.43 | 9.26 | 22.07 | 20.87 | 6.80 | 5.34 | 1.04 | 13.83 | 0.3628 | 44.18 | 33.95 | 19.26 | 51.05 | 32.29 | 10.66 | 30.76 |
| Akron PAO | 15.78bn | 5.37bn | 64.04bn | 11.21k | 12.08 | 7.88 | 9.79 | 4.06 | 1,562.54 | 1,562.54 | 4,595.30 | 2,395.29 | 0.7354 | 2.99 | 21.09 | -- | 25.34 | 8.40 | 35.98 | 12.17 | 59.90 | 47.34 | 34.46 | 15.83 | 1.10 | -- | 0.4489 | 81.99 | 4.38 | 5.43 | -86.33 | -26.95 | 3.50 | -19.73 |
| Evonik Industries AG | 134.02bn | 2.03bn | 66.97bn | 33.92k | 32.69 | 0.8379 | 4.73 | 0.4997 | 0.5902 | 0.5924 | 38.56 | 23.03 | 0.7981 | 4.74 | 8.20 | 528,813.70 | 1.26 | 3.11 | 1.60 | 3.73 | 21.51 | 26.78 | 1.58 | 4.59 | 0.9947 | -- | 0.292 | 83.64 | 23.62 | 5.15 | -27.94 | -5.44 | -3.62 | 0.3454 |
| Yara International ASA | 153.38bn | 13.44bn | 67.39bn | 17.50k | 5.02 | 1.11 | 3.34 | 0.4394 | 85.03 | 85.03 | 970.71 | 383.64 | 1.22 | 3.80 | 8.79 | 14,131,960.00 | 10.68 | 5.45 | 14.69 | 7.11 | 25.58 | 27.09 | 8.77 | 5.89 | 1.08 | 11.03 | 0.3252 | 68.87 | 43.84 | 16.05 | 518.49 | 42.24 | -7.25 | 52.98 |
| Chr Hansen Holding A/S | 9.63bn | 1.70bn | 68.40bn | 3.69k | 40.13 | 5.13 | 27.07 | 7.10 | 12.93 | 12.93 | 73.18 | 101.20 | 0.3995 | 3.23 | 6.92 | 2,607,823.00 | 7.06 | 8.94 | 7.99 | 11.09 | 54.74 | 57.57 | 17.67 | 21.00 | 0.9702 | 10.09 | 0.3677 | 62.46 | 13.05 | 2.77 | 13.29 | 0.098 | 5.96 | -10.07 |
| Novozymes A/S | 17.81bn | 3.63bn | 78.43bn | 6.79k | 26.48 | 7.42 | 15.29 | 4.40 | 13.03 | 13.03 | 63.96 | 46.50 | 0.6649 | 2.35 | 4.91 | 2,765,611.00 | 13.62 | 14.77 | 18.85 | 19.53 | 54.22 | 56.26 | 20.49 | 21.31 | 0.8066 | 23.91 | 0.3839 | 47.37 | 17.40 | 3.85 | 16.85 | 3.34 | 11.30 | 5.92 |
| Brenntag SE | 144.66bn | 6.36bn | 86.16bn | 17.50k | 13.55 | 2.62 | 9.34 | 0.5956 | 5.52 | 5.52 | 125.78 | 28.54 | 1.76 | 8.70 | 7.08 | 1,107,372.00 | 7.85 | 6.30 | 12.14 | 8.88 | 22.28 | 22.40 | 4.46 | 3.90 | 1.08 | 17.91 | 0.4129 | 35.95 | 35.09 | 10.59 | 97.81 | 19.70 | 12.03 | 12.70 |
| PhosAgro PAO | -9.23bn | -9.23bn | 90.77bn | 25.00k | -- | 5.95 | -- | -- | -- | -- | -- | 1,277.21 | -- | -- | -- | -- | -- | 24.15 | -- | 30.90 | -- | 46.59 | -- | 23.35 | 0.7324 | -- | 0.5647 | 87.79 | 35.44 | 25.72 | 42.38 | 48.78 | 12.20 | 80.76 |
| Akzo Nobel NV | 81.76bn | 2.26bn | 90.88bn | 32.90k | 41.02 | 2.76 | 17.53 | 1.11 | 1.75 | 1.68 | 63.25 | 25.90 | 0.7242 | 3.82 | 4.21 | 311,875.00 | 2.16 | 3.95 | 3.48 | 5.60 | 35.74 | 41.07 | 2.99 | 6.18 | 0.7729 | 9.09 | 0.5551 | 67.83 | 13.13 | 2.45 | -56.01 | -3.78 | 3.15 | -6.78 |
Data as of May 31 2023. Currency figures normalised to Novozymes A/S's reporting currency: Danish Krone DKK
17.99%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Baillie Gifford & Co.as of 25 May 2023 | 6.84m | 3.01% |
| The Vanguard Group, Inc.as of 05 May 2023 | 5.33m | 2.35% |
| Norges Bank Investment Managementas of 31 Dec 2022 | 4.83m | 2.12% |
| MFS International (UK) Ltd.as of 30 Apr 2023 | 4.79m | 2.11% |
| BlackRock Fund Advisorsas of 04 May 2023 | 3.79m | 1.67% |
| Impax Asset Management Ltd.as of 28 Apr 2023 | 3.78m | 1.66% |
| Pictet Asset Management SAas of 30 Apr 2023 | 3.57m | 1.57% |
| Handelsbanken Fonder ABas of 30 Apr 2023 | 3.02m | 1.33% |
| Harding Loevner LPas of 30 Apr 2023 | 2.60m | 1.14% |
| Walter Scott & Partners Ltd.as of 25 May 2023 | 2.33m | 1.03% |
More ▼
Data from 31 Dec 2022 - 30 Apr 2023Source: FactSet Research Systems Inc.
